GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Deferred Tax

ZYUS Life Sciences (TSXV:ZYUS) Deferred Tax : C$-5.85 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

ZYUS Life Sciences's change in deferred tax for the three months ended in Mar. 2024 was C$-0.02 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was C$-5.85 Mil.

ZYUS Life Sciences Deferred Tax Historical Data

The historical data trend for ZYUS Life Sciences's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Deferred Tax Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Deferred Tax
-0.12 -0.06 -5.85

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.02 -0.02 -5.79 -0.02

ZYUS Life Sciences Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-5.85 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ZYUS Life Sciences Deferred Tax Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

ZYUS Life Sciences (TSXV:ZYUS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Deferred Tax
Comparable Companies
TSXV:DB XCNQ:HUGE TSX:CWEB XCNQ:GRIN TSX:MDP TSX:CRDL XCNQ:CXXI XCNQ:MMEN TSX:AVNT XCNQ:ACRG.A.U ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ZLSCF:USA
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
Website
https://www.zyus.com
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines